US EditionPublished • loading... • Updated
Rick Suárez: "Astrazeneca's Investment in Barcelona Equals the Annual R & D of the Sector in Spain"
Summary by Expansión
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.5 Articles
5 Articles
Merca2.es+3 Reposted by 3 other sources
AstraZeneca has inaugurated the new headquarters of the AstraZeneca Global Hub of Barcelona, a space that marks the beginning of a new stage of growth for the company and consolidates the Catalan capital as one of the most important biomedical and technological innovation poles in Europe. The multinational has planned an investment of 1.3 billion euros until 2027, a figure equivalent to all the annual investment in R & D of the entire pharmaceut…
The pharmaceutical giant has inaugurated its biomedical research and digitization hub in the Catalan capital this Monday, which has meant an investment of 1.3 billion. Read
Coverage Details
Total News Sources5
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
